These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Heat shock protein 90 inhibition is cytotoxic to primary AML cells expressing mutant FLT3 and results in altered downstream signalling. Al Shaer L; Walsby E; Gilkes A; Tonks A; Walsh V; Mills K; Burnett A; Rowntree C Br J Haematol; 2008 May; 141(4):483-93. PubMed ID: 18373709 [TBL] [Abstract][Full Text] [Related]
8. [Changes in heat shock protein synthesis and thermotolerance of Arabidopsis thaliana seedlings as a result of inhibition of Hsp90 by geldanamycin]. Kozeko LG Tsitologiia; 2014; 56(6):419-26. PubMed ID: 25696978 [TBL] [Abstract][Full Text] [Related]
9. [Effect of geldanamycin on the expression of signal proteins and heat shock proteins in normal mice lymphocytes]. Novoselova TV; Cherenkov DA; Khrenov MO; Glushkova OV; Lunin SM; Novoselova EG; Fesenko EE Tsitologiia; 2008; 50(7):629-35. PubMed ID: 18771179 [TBL] [Abstract][Full Text] [Related]
10. Co-inhibition of HSP70/HSP90 synergistically sensitizes nasopharyngeal carcinoma cells to thermotherapy. Cui XB; Yu ZY; Wang W; Zheng YQ; Liu W; Li LX Integr Cancer Ther; 2012 Mar; 11(1):61-7. PubMed ID: 21498475 [TBL] [Abstract][Full Text] [Related]
12. Abrogation of heat shock protein 70 induction as a strategy to increase antileukemia activity of heat shock protein 90 inhibitor 17-allylamino-demethoxy geldanamycin. Guo F; Rocha K; Bali P; Pranpat M; Fiskus W; Boyapalle S; Kumaraswamy S; Balasis M; Greedy B; Armitage ES; Lawrence N; Bhalla K Cancer Res; 2005 Nov; 65(22):10536-44. PubMed ID: 16288046 [TBL] [Abstract][Full Text] [Related]
13. Expression profile of heat shock proteins in acute myeloid leukaemia patients reveals a distinct signature strongly associated with FLT3 mutation status--consequences and potentials for pharmacological intervention. Reikvam H; Hatfield KJ; Ersvaer E; Hovland R; Skavland J; Gjertsen BT; Petersen K; Bruserud O Br J Haematol; 2012 Feb; 156(4):468-80. PubMed ID: 22150087 [TBL] [Abstract][Full Text] [Related]
14. Radicicol but not geldanamycin evokes oxidative stress response and efflux protein inhibition in ARPE-19 human retinal pigment epithelial cells. Ryhänen T; Mannermaa E; Oksala N; Viiri J; Paimela T; Salminen A; Atalay M; Kaarniranta K Eur J Pharmacol; 2008 Apr; 584(2-3):229-36. PubMed ID: 18313664 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of constitutive and cxc-chemokine-induced NF-kappaB activity potentiates ansamycin-based HSP90-inhibitor cytotoxicity in castrate-resistant prostate cancer cells. Seaton A; Maxwell PJ; Hill A; Gallagher R; Pettigrew J; Wilson RH; Waugh DJ Br J Cancer; 2009 Nov; 101(9):1620-9. PubMed ID: 19809428 [TBL] [Abstract][Full Text] [Related]
16. Hsp90 inhibitors attenuate effect of dexamethasone on activated NF-kappaB and AP-1. Tago K; Tsukahara F; Naruse M; Yoshioka T; Takano K Life Sci; 2004 Mar; 74(16):1981-92. PubMed ID: 14967193 [TBL] [Abstract][Full Text] [Related]
17. Anti-proliferative activity of heat shock protein (Hsp) 90 inhibitors via beta-catenin/TCF7L2 pathway in adult T cell leukemia cells. Kurashina R; Ohyashiki JH; Kobayashi C; Hamamura R; Zhang Y; Hirano T; Ohyashiki K Cancer Lett; 2009 Oct; 284(1):62-70. PubMed ID: 19464103 [TBL] [Abstract][Full Text] [Related]
18. In vitro study comparing the efficacy of the water-soluble HSP90 inhibitors, 17-AEPGA and 17-DMAG, with that of the non‑water-soluble HSP90 inhibitor, 17-AAG, in breast cancer cell lines. Ghadban T; Jessen A; Reeh M; Dibbern JL; Mahner S; Mueller V; Wellner UF; Güngör C; Izbicki JR; Vashist YK Int J Mol Med; 2016 Oct; 38(4):1296-302. PubMed ID: 27498942 [TBL] [Abstract][Full Text] [Related]
19. Hsp90 inhibitor geldanamycin attenuates the cytotoxicity of sunitinib in cardiomyocytes via inhibition of the autophagy pathway. Kimura T; Uesugi M; Takase K; Miyamoto N; Sawada K Toxicol Appl Pharmacol; 2017 Aug; 329():282-292. PubMed ID: 28624441 [TBL] [Abstract][Full Text] [Related]
20. Molecular and biologic characterization and drug sensitivity of pan-histone deacetylase inhibitor-resistant acute myeloid leukemia cells. Fiskus W; Rao R; Fernandez P; Herger B; Yang Y; Chen J; Kolhe R; Mandawat A; Wang Y; Joshi R; Eaton K; Lee P; Atadja P; Peiper S; Bhalla K Blood; 2008 Oct; 112(7):2896-905. PubMed ID: 18660379 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]